Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats

Abstract

Background Hybrid positron emission tomography and magnetic resonance imaging (PET/MRI) scanners are increasingly used for both clinical and preclinical imaging. Especially functional MRI sequences such as diffusion-weighted imaging (DWI) are of great interest as they provide information on a molecular level, thus, can be used as surrogate biomarkers. Due to technical restrictions, MR sequences need to be adapted for each system to perform reliable imaging. There is, to our knowledge, no suitable DWI protocol for 1 Tesla PET/MRI scanners. We aimed to establish such DWI protocol with focus on the choice of b values, suitable for longitudinal monitoring of tumor characteristics in a rat liver tumor model. Material and methods DWI was first performed in 18 healthy rat livers using the scanner-dependent maximum of 4 b values (0, 100, 200, 300 s/mm 2 ). Apparent diffusion coefficients (ADC) were calculated from different b value combinations and compared to the reference measurement with four b values. T2-weighted MRI and optimized DWI with best agreement between accuracy, scanning time, and system performance stability were used to monitor orthotopic hepatocellular carcinomas (HCC) in five rats of which three underwent additional 2-deoxy-2-( 18 F)fluoro- d -glucose(FDG)-PET imaging. ADCs were calculated for the tumor and the surrounding liver parenchyma and verified by histopathological analysis. Results Compared to the reference measurements, the combination b = 0, 200, 300 s/mm 2 showed the highest correlation coefficient ( r s = 0.92) and agreement while reducing the acquisition time. However, measurements with less than four b values yielded significantly higher ADCs ( p < 0.001). When monitoring the HCC, an expected drop of the ADC was observed over time. These findings were paralleled by FDG-PET showing both an increase in tumor size and uptake heterogeneity. Interestingly, surrounding liver parenchyma also showed a change in ADC values revealing varying levels of inflammation by immunohistochemistry. Conclusion We established a respiratory-gated DWI protocol for a preclinical 1 T PET/MRI scanner allowing to monitor growth-related changes in ADC values of orthotopic HCC liver tumors. By monitoring the changes in tumor ADCs over time, different cellular stages were described. However, each study needs to adapt the protocol further according to their question to generate best possible results. Electronic supplementary material The online version of this article (10.1186/s13550-019-0489-6) contains supplementary material, which is available to authori...

A Novel Histological Technique to Assess Severity of Traumatic Brain Injury in Rodents: Comparisons to Neuroimaging and Neurological Outcomes

“…However, we believe that this important parameter affects the accuracy of the measurement ( Boyko et al, 2019b ; Kuts et al, 2019a ) and therefore was used in our protocol. It should also be mentioned that this parameter is influenced by many factors, including the size of the brain ( Yushmanov et al, 2002 ; Purushotham et al, 2015 ), brain region ( Yuan et al, 2017 ), model of the disease under study ( Bardutzky et al, 2005 ; Albrecht et al, 2019 ) and age-related trends in the rat ( Bardutzky et al, 2005 ; Bontempi et al, 2021 ). We used the recommended optimal threshold parameters for correction of ADC maps ( Benveniste et al, 1992 ; Yushmanov et al, 2002 ; Meng et al, 2004 ; Bra et al, 2009 ), which have been tested in rat ischemia models ( Boyko et al, 2019b ).…”

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? – A preclinical assessment in vitro and in vivo

“…The viable tumor area was determined as previously described [40] , using PMOD software version 3.505 (PMOD Technologies, Zürich, Switzerland). Briefly, a whole tumor region of interest (ROI) was placed onto the T2w images and copied to fused PET/MRI images.…”

Multimodal Imaging of 2-Cycle PRRT with 177Lu-DOTA-JR11 and 177Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model

“…Metabolically active tumor tissue was determined by fused 18 F-FDG PET and T2-weighted MRI as previously described (15). Briefly, a tumor volume of interest was placed onto T2-weighted images.…”